Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedNew registry identifiers UTN and EU CT were added and old registry references updated. The page now includes links for trial transparency data sharing (trialstransparency PDF) and external data sharing site.SummaryDifference0.3%

- Check29 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1.SummaryDifference0.0%

- Check36 days agoChange DetectedMinor update: the page now displays Revision: v3.4.1 and removes Revision: v3.4.0, indicating a small version bump. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded show/hide glossary controls and updated footer labels (including capitalization changes for QC criteria and FEAR Act data) with Revision: v3.4.0.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision update: added v3.3.4 and removed v3.3.3. This appears to be an internal version-control change with no user-facing content changes.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.